Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?

Today's Daily Dose brings you news about preliminary financial results of Globus Medical, Conformis, and GenMark Diagnostics; approval of Amgen's Evenity in Japan; Genmab's achievement of a milestone payment related to Darzalex; and executive changes in Abeona.

from RTT - Biotech http://bit.ly/2RISbSs
via IFTTT